Disc Medicine, Inc. (IRON)
61.18
+0.84
(+1.39%)
USD |
NASDAQ |
Mar 06, 16:00
67.25
+6.07
(+9.92%)
After-Hours: 20:00
Disc Medicine SG&A Expense (TTM) : 65.38M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Boston Scientific Corp. | 6.888B |
| Penumbra, Inc. | 663.42M |
| Rapt Therapeutics, Inc. | 29.76M |
| Amylyx Pharmaceuticals, Inc. | 62.89M |